AI & Healthcare News — 2026-11-08 (Sun) Daily News

Overview

Mental health: a yearlong trial of an AI chatbot for pregnant women and new mothers did not ease anxiety or depression, while funding and app launches continued (Medical Daily, Dealroom, Bioengineer.org). Physical health: smartwatch, eye-scan and CGM-based detection and monitoring stories dominated, mostly at the research or announcement stage (jetstream.blog, News Mobile, EurekAlert!). Systems: coverage touched FDA's request for information on AI in early phase clinical trials, an award for AEYE Health, and workplace anxiety over AI (Crowell & Moring LLP, The Jerusalem Post, The Guardian).

Mental health

- A trial of the AI chatbot Rosie ran for a year among pregnant women and new mothers. The headline says it "Did Not Ease Anxiety or Depression". The headline gives no sample size or design details (Medical Daily). - The bilingual smartphone app REWAA integrates mood tracking, AI tools and therapy. The headline gives no evidence of effect (Bioengineer.org). - The founders of Nurx and Journey Clinical raised $6M for the AI mental health startup Siggy (Dealroom). - GLAAD published a 2026 AI report on impacts on LGBTQ people across AI. The headline gives no health findings (GLAAD).

Exercise and physical activity

- A Philadelphia report describes AI-powered fitness that uses adaptive technology to support healthy aging. The headline gives no outcome data (6abc Philadelphia). - A study maps the rapid rise of AI in wearable smart textiles. The headline describes a mapping of the field, not a health outcome (Bioengineer.org).

Sleep

No notable developments.

Nutrition and diet

- A Nikkei reporter spent two weeks testing how far AI can predict post-meal blood glucose swings. The headline reports a personal trial, not a controlled study (Nikkei). - Korea released an AI app to support obesity management and treatment. The headline gives no evidence of effect (Vietnam.vn).

Prevention and screening

- An Iowa hospital is expanding colon cancer screening with AI technology. The headline does not give detection figures (American Hospital Association). - AI-powered eye scans may help detect diabetes and heart disease early. The headline says "may" and does not state the study stage or population (News Mobile). 【Chronic disease self-management】 - A Chinese Medical Journal article review explores AI-powered analysis of continuous glucose monitor (CGM) data in diabetes care. This is a review, not a trial (EurekAlert!). - Google announced an AI technology called "AI-PPG-ACC-HTN" to detect signs of hypertension on smartwatches. The headline gives no validation data (jetstream.blog). - Korean pharmaceutical companies are pivoting to digital health as AI predicts blindness and heart failure. The headline gives no performance figures (Chosunbiz).

Older adults and caregiving

- An Exeter-led research hub will develop AI tools for early dementia diagnosis. This is a plan for development, not results (Exeter Today). 【Digital therapeutics and regulation】 - US: law firm Crowell & Moring describes FDA's request for information on AI in early phase clinical trials as an opportunity to help set the rules (Crowell & Moring LLP). - Israel/US: AEYE Health won the Prix Galien Award for AI technology to help prevent blindness. The headline gives no approval details (The Jerusalem Post). - HIMSS is giving AI a bigger role in its digital health assessment (DesignRush). - US: a MedCity News episode covered the CVS Health restructure, AI ROI report findings and FTC warning letters. The headline does not say what the letters concerned (MedCity News).

Workplace health

- White-collar workers fearing AI disruption are quitting their jobs (The Guardian). - Workers face many invisible pressures as AI develops (Vietnam.vn). - NewJeans members reportedly signed contracts at ages 14-17 that omitted sleep protections and gave the label rights to their AI-generated voices. The headline says "Reportedly" (International Business Times UK).

Developments in Japan

- TISI is strengthening its preventive medicine business with AI-based contactless vital sign measurement (VOIX news media). - Hitachi, Ltd. and Hitachi city in Ibaraki are running a pilot of AI for welfare consultations (Mainichi Shimbun). - Nikkei ran the two-week blood glucose prediction trial described in section 5 (Nikkei). - Separately, a Japanese-language report says Thailand is promoting medical AI and precision medicine, with a target of a health-related economy equivalent to 16 trillion yen by 2032 (newsclip.be).

Statements from key figures

No notable developments.

AI videos and explainers

No notable developments.